Path: ...!news.mixmin.net!proxad.net!feeder1-2.proxad.net!usenet-fr.net!pasdenom.info!from-devjntp
Message-ID: <vjYd6P9hrf9GEQ3_1WseOQPBVOk@jntp>
JNTP-Route: nemoweb.net
JNTP-DataType: Article
Subject: Re: Vaccins muqueux =?UTF-8?Q?=3F?=
References: <HPaOO.1075990$jVLc.881746@fx15.ams4> <TtfCbnufzynlMMWyxByt71gd5fg@jntp> <mn.63ad7e8a1ac62fa2.119180@invalid.pasdepub>
 <_sif2nboBl6bB-iZEHCDgj7ml9A@jntp> <mn.6ca67e8a7a506d65.119180@invalid.pasdepub>
Newsgroups: fr.misc.actualite.covid19
JNTP-HashClient: JpSHU2C4V3uEEpuBJZj1mxTc5WI
JNTP-ThreadID: HPaOO.1075990$jVLc.881746@fx15.ams4
JNTP-Uri: https://nemoweb.net/?DataID=vjYd6P9hrf9GEQ3_1WseOQPBVOk@jntp
User-Agent: Nemo/1.0
JNTP-OriginServer: nemoweb.net
Date: Sun, 13 Oct 24 18:42:28 +0000
Organization: Nemoweb
JNTP-Browser: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:131.0) Gecko/20100101 Firefox/131.0
Injection-Info: nemoweb.net; posting-host="48db87d9176ce6969124ceb9d6b05e62333c6c22"; logging-data="2024-10-13T18:42:28Z/9059780"; posting-account="2@nemoweb.net"; mail-complaints-to="julien.arlandis@gmail.com"
JNTP-ProtocolVersion: 0.21.1
JNTP-Server: PhpNemoServer/0.94.5
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
X-JNTP-JsonNewsGateway: 0.96
From: Duzz' <jsuis@jreste.invalid>
Bytes: 1811
Lines: 11

Le 13/10/2024 à 19:50, Geo a écrit :
> De Duzz', le 12/10/2024 :
>>
>> Les recherches initiées en 2021 à la Faculté de Pharmacie de Tours, semblent 
>> être en bonne voie :
>> 
>> <https://www.francebleu.fr/infos/sante-sciences/vaccin-nasal-contre-le-covid-19-developpe-a-tours-la-start-up-lovaltech-leve-7-millions-d-euros-8467365>
> 
> Avec Aubrin en spécialiste :
> Message ID : <ue13u3$35c4s$2@dont-email.me>

:-D